Company intelligence / Profile preview
Bristol Myers Squibb
New York, New York, United Statesbms.com ↗
- Ownership
- Public · BMY
- Employees
- ~54500
- Development stage
- Other
01
Overview
BMS has a robust pipeline with over forty-four compounds in development across more than forty disease areas. It has numerous drugs in advanced clinical stages including Phase II and Phase III trials targeting cancer, immune disorders, and other serious conditions. The company also markets several approved blockbuster drugs such as Opdivo® and Eliquis® that have transformed treatment paradigms in oncology and cardiovascular medicine
- Therapeutic areas
- CardiovascularImmunologyHematologyOncologyRare DiseasesNeurology
- Modalities
- Small moleculesMonoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Other biologics and novel therapies
- Industry
- Pharma
02
Drug pipeline
611 assets610 more assets in the full pipeline.
03
Partnerships
Collaborations with Ono Pharmaceutical for immuno-oncology agentsZai Lab for Asian market developmentsProthena for neurodegenerative targetsJohnson & Johnson on anticoagulantsMerck on REBLOZYL drug developmentHalozyme for drug delivery technologies among others
04
Financials
- Market cap
- $129B
- Total revenue
- $48.2B
- Enterprise value
- $161.3B
Beyond the preview
Go deeper on Bristol Myers Squibb.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bristol Myers Squibb.